List Of Figures
|
| Figure # |
|
| Chapter II - Data Sources
and Structure |
| II-1 |
Transplantation
Research Data Organization, Primary and Secondary Sources |
| II-2 |
Data
Submission and Data Flow, Primary and Secondary Sources |
|
| Chapter III - Organ Donation |
III-1
| Organ
Procurement Organization Service Areas |
| III-2 |
OPTN/UNOS
Regional Map |
| III-3 |
Nonrecovery
of Consented Organs, 2001 |
| III-4 |
Deceased
and Living Donors, 1992-2001 |
| III-5 |
Annualized
Rates of Change in Organ Donation Statistics, 1996-2001 |
| III-6 |
Average
Donor Age, by Living or Deceased Donor, 1996 vs. 2001 |
| III-7 |
Donor
Sex, by Living or Deceased Donor, 1996 vs. 2001 |
| III-8 |
Donor
Race, by Living or Deceased Donor, 1996 vs. 2001 |
| III-9 |
Donor
Blood Type, by Living or Deceased Donor, 2001 |
| III-10 |
Living
Donor Relationship to Recipient, 1992, 1996, and 2001 |
| III-11 |
Annual
Deceased Organ Donor & U.S. Population Changes,1992-2001 |
| III-12 |
Median
Age of Deceased Organ Donors and U.S. Population |
| III-13 |
Race
of Deceased Organ Donors and U.S. Population, 2001 |
| III-14 |
Percent
Cause of Death for Organ Donors, 1995 vs. 2001 |
| III-15 |
Organ
Recovery Rates from Deceased Donors, 2001 |
| III-16 |
Distribution
of Cadaveric Organ Donations by Age, 2001 |
| III-17 |
Cadaveric
Organ Recovery Outcomes, 2001 |
|
| Chapter IV - Immunosuppression
Practice and Trends |
| IV-1 |
Kidney
Transplant Immunosuppression Prior to Discharge: Cyclosporine vs. Tacrolimus,1993-2001 |
| IV-2 |
Kidney-Pancreas
Transplant Immunosuppression Prior to Discharge: Cyclosporine vs. Tacrolimus,1993-2001 |
| IV-3 |
Kidney-Pancreas
Transplant Immunosuppression Prior to Discharge: Azathioprine, Mycophenolate
Mofetil, and Rapamycin, 1993-2001 |
| IV-4 |
Incidence
of Rejection at 1 Year in Kidney, Pancreas and Kidney-Pancreas Transplant
Recipients, 1992-2000 |
| IV-5 |
Liver
Transplant Immunosuppression Prior to Discharge: Cyclosporine vs. Tacrolimus,
1993-2001 |
| IV-6 |
Liver
Transplant Immunosuppression Prior to Discharge: Azathioprine vs. Mycophenolate
Mofetil, 1993-2001 |
| IV-7 |
Incidence
of Rejection at 1 Year in Liver Transplant Recipients, 1992-2000 |
| IV-8 |
Use
of Antibody Therapy for Rejection Episodes Following Liver Transplantation,
1992-2000 |
| IV-9 |
Trends
in Antibody Therapy for Rejection Episodes Following Liver Transplantation,1996-2000 |
| IV-10 |
Intestine
Transplant Immunosuppression Prior to Discharge: Use of Mycophenolate Mofetil,
1993-2001 |
| IV-11 |
Incidence
of Rejection at 1 Year in Intestine Transplant Recipients, 1992-2000 |
| IV-12 |
Percentage
of Recipients With Antirejection Treatment by Year of Transplant, 1992-2000 |
|
| Chapter V - Pediatric
Transplantation |
| V-1 |
Deceased
Donors by Organ, Adult vs. Pediatric, 2001 |
| V-2 |
Deceased
Pediatric Donors by Organ and Age Group, 2001 |
| V-3 |
Percent
Donation of Organs of Adult and Pediatric Deceased Donors, 2001 |
| V-4 |
Graft
Survival Among Recipients of Living Donor Kidney Transplants, by Recipient
Age |
| V-5 |
Patient
Survival Among Pediatric Recipients of Deceased Donor Liver Transplants,
by Recipient Age |
| V-6 |
Patient
Survival Among Pediatric Recipients of Living Donor Liver Transplants, by
Recipient Age |
| V-7 |
Patient
Survival Among Pediatric Recipients of Deceased Donor Intestine Transplants,
by Recipient Age |
| V-8 |
Patient
Survival Among Pediatric Recipients of Deceased Donor Heart Transplants,
by Recipient Age |
| V-9 |
Pediatric
Lung Waitlist Death Rates Per 1,000 Patient Years at Risk By Recipient Age,
1992-2001 |
| V-10 |
Patient
Survival Among Pediatric Recipients of Deceased Donor Lung Transplants,
by Recipient Age |
|
| Chapter VI - Kidney and
Pancreas Transplantation |
| VI-1 |
Growth
in the Waiting List for Deceased Donor Kidneys, by Total Registrations at
Year-End and New Registrations per Calendar Year, 1992-2001 |
| VI-2 |
Percentage
Growth in New Registrations for Deceased Donor Kidney Waiting List, 1993-2001 |
| VI-3 |
Year-End
Point Prevalence of ESRD Cases in the United States, 1991-1999 |
| VI-4 |
Peak
PRA of Registrants on Deceased Donor Kidney Waiting List at Year-End, 1992-2001 |
| VI-5 |
Mean
Age in Years of Kidney Transplant Candidates on the Waiting List at Year-End,1992-2001 |
| VI-6 |
Percentage
on the Kidney Waiting List, by Age Group, 1992-2001 |
| VI-7 |
Percentage
on the Kidney Waiting List, by Race, 1992-2001 |
| VI-8 |
Waiting
Time for Registrants on Deceased Donor Kidney Waiting List, 1992-2001 |
| VI-9 |
Death
Rates on the Deceased Donor Kidney Waiting List by Race, 1992-2001 |
| VI-10 |
Median
Time to Deceased Donor Kidney Transplant Among Registrants Waitlisted in
1992 and 1997, by Race and Ethnicity |
| VI-11 |
Median
Time to Deceased Donor Kidney Transplant Among Registrants Waitlisted in
1992 and 1997, by ABO Blood Type |
| VI-12 |
Kidney
Transplants Performed in the United States, by Year and Donor Source, 1992-2001 |
| VI-13 |
Patient
Survival at Five Years after Kidney Transplantation, by Recipient Age and
Donor Source |
| VI-14 |
Patient
and Graft Survival at Five Years After Deceased Donor Kidney Transplantation,
by Recipient Age |
| VI-15 |
Graft
Survival Five Years after Deceased Donor Kidney Transplantation, by Donor
Age |
| VI-16 |
Percentage
Difference from the Mean in Graft Survival Five Years after Deceased Donor
Kidney Transplantation, by HLA A, B, and DR Mismatch |
| VI-17 |
Graft
Survival Among Kidney Transplant Recipients |
| VI-18 |
Pancreas
Transplant Numbers by Category, 1992-2001 |
| VI-19 |
Pancreas
Graft Survival Among Pancreas Transplant Recipients |
|
| Chapter VII - Liver and
Intestine Transplantation |
| VII-1 |
Registrants
on the Liver Waiting List, 1992-2001 |
| VII-2 |
Registrants
Waiting Two Years or More for a Liver Transplant |
| VII-3 |
Deaths
on the Liver Waiting List, 1992-2001 |
| VII-4 |
Death
Rate Per 1,000 Patient Years at Risk, by Status at Listing, 2001 |
| VII-5 |
Death
Rates Per 1,000 Patient Years at Risk, Liver Transplant Recipients vs. Liver
Waiting List, 1992-2001 |
| VII-6 |
Living
Liver Donor Transplants, Adults vs. Pediatrics, 1992-2001 |
| VII-7 |
Graft
Survival Among Liver Transplant Recipients, Living vs. Deceased Donor |
| VII-8 |
Patient
Survival Among Liver Transplant Recipients, Living vs. Deceased Donor |
| VII-9 |
MELD
and PELD Mortality Risks at Three Months for 1,230 Adult and 649 Pediatric
Patients Added to Waiting List Between 3/1/01 and 8/15/01 |
| VII-10 |
Adult
Registrants on Liver Waiting List by MELD Score |
| VII-11 |
Pediatric
Registrants on Liver Waiting List by PELD Score |
| VII-12 |
Percentage
of Adult Registrants on Liver Waiting List Transplanted Within 30 Days of
Listing by MELD Score |
| VII-13 |
Percentage
of Pediatric Registrants on Liver Waiting List Transplanted Within 30 Days
of Listing by PELD Score |
| VII-14 |
Percentage
of Adult Deaths on Liver Waiting List Within 30 Days of Listing by MELD
Score |
| VII-15 |
Percentage
of Pediatric Deaths on Liver Waiting List Within 30 Days of Listing by PELD
Score |
| VII-16 |
Percentage
of Intestine Transplant Recipients Hospitalized or in Intensive Care Unit
at Transplant, 1992-2001 |
| VII-17 |
Graft
vs. Patient Survival Among Intestine Transplant Recipients |
|
| Chapter VIII - Thoracic
Organ Transplantation |
| VIII-1 |
Age
Distribution of Heart Waiting List Registrants at Year-End, 1992-2001 |
| VIII-2 |
Accrued
Waiting Time for Heart Waiting List Registrants at Year-End, 1992-2001 |
| VIII-3 |
Median
Time to Heart Transplant, by Year, 1992-2001 |
| VIII-4 |
>Median
Time to Heart Transplant by ABO Blood Type, 2000 |
| VIII-5 |
Patient
Survival Among Heart Transplant Recipients |
| VIII-6 |
Active
vs. Inactive Lung Waiting List Registrants at Year-End, 1995-2001 |
| VIII-7 |
Age
Distribution of Lung Waiting List at Year-End, 1992-2001 |
| VIII-8 |
25th
Percentile Time to Transplant of New Lung Waiting List Registrants, 1992-2001 |
| VIII-9 |
Annual
Death Rates Per Thousand Patient Years at Risk on the Lung Waitling List,
1992-2001 |
| VIII-10 |
Percent
of Patients Undergoing Single-Lung Transplantation, Double-Lung Transplantation
and the Indication for Transplantation, 1992-2001 |
| VIII-11 |
Annual
Death Rates for Lung Transplant Recipients by Race and Total, 1992-2001 |
| VIII-12 |
Annual
Death Rates for Lung Transplant Recipients by Gender and Total, 1992-2001 |
| VIII-13 |
Annual
Death Rates for Lung Transplant Recipients by Diagnosis, 1992-2001 |
| VIII-14 |
Graft
Survival Among Lung Transplant Recipients as a Function of Transplant Volume |
| VIII-15 |
Patient
Survival Among Lung Transplant Recipients as a Function of Transplant Volume |
|
| Chapter X - Special Focus
Area: Expanded Criteria Donors for Kidney Transplantation |
| X-1 |
Patient
Survival After ECD or Non-ECD Transplant, by Recipient Age |
|
APPENDIX FIGURES
|
| Appendix H - Research
and Data Requests |
| H-1 |
OPTN Research Data Requests,
1992 to 2001 |
| H-2 |
Number
of SRTR Nongovernment Data Requests |
|
Appendix I - OPTN Data Flow |
| I-1 |
OPTN
Data Flow 870 of Recipients With Antirejection Treatment by Year of Transplant,
1992-2000 |
